We've never been stronger, and where there is this much potential for regulatory and commercial success, there is likely to be serious financial interest in capitalizing on Humanigen's success.
Will management be able to meet their financial requirements exclusively through a 5:1 forward stock split?
Or will it be necessary to continue the controlled equity offering and initiate a Private Placement as well?
Or, can we mitigate the increase to our Outstanding Shares through the reception of an Advanced Purchase Agreement?